Prostaglandin EP4 receptor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prostaglandin EP4 receptor" in English language version.

refsWebsite

Global rank English rank

33nih.gov

4^th place

18doi.org

2^nd place

9web.archive.org

1^st place

7semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1guidetopharmacology.org

low place

1harvard.edu

18^th place

17^th place

1handle.net

102^nd place

76^th place

doi.org

Woodward DF, Jones RL, Narumiya S (September 2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
Ichikawa A, Sugimoto Y, Tanaka S (2010). "Molecular biology of histidine decarboxylase and prostaglandin receptors". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (8): 848–66. Bibcode:2010PJAB...86..848I. doi:10.2183/pjab.86.848. PMC 3037517. PMID 20948178.
Pang L, Cai Y, Tang EH, Irwin MG, Ma H, Xia Z (2016). "Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy". Journal of Diabetes Research. 2016: 1324347. doi:10.1155/2016/1324347. PMC 4846751. PMID 27190998.
Narumiya S, Sugimoto Y, Ushikubi F (October 1999). "Prostanoid receptors: structures, properties, and functions". Physiological Reviews. 79 (4): 1193–226. doi:10.1152/physrev.1999.79.4.1193. PMID 10508233. S2CID 7766467.
Markovič T, Jakopin Ž, Dolenc MS, Mlinarič-Raščan I (January 2017). "Structural features of subtype-selective EP receptor modulators". Drug Discovery Today. 22 (1): 57–71. doi:10.1016/j.drudis.2016.08.003. PMID 27506873.
Moreno JJ (February 2017). "Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis". European Journal of Pharmacology. 796: 7–19. doi:10.1016/j.ejphar.2016.12.004. PMID 27940058. S2CID 1513449.
Kalinski P (January 2012). "Regulation of immune responses by prostaglandin E2". Journal of Immunology. 188 (1): 21–8. doi:10.4049/jimmunol.1101029. PMC 3249979. PMID 22187483.
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014). "Cyclooxygenase pathways". Acta Biochimica Polonica. 61 (4): 639–49. doi:10.18388/abp.2014_1825. PMID 25343148.
Ushikubi F, Sugimoto Y, Ichikawa A, Narumiya S (August 2000). "Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors". Japanese Journal of Pharmacology. 83 (4): 279–85. doi:10.1254/jjp.83.279. PMID 11001172.
Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR, Skoll A, Vazquez A, Gobeil F, Clyman RI, Chemtob S (May 2001). "Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus". American Journal of Physiology. Heart and Circulatory Physiology. 280 (5): H2342-9. doi:10.1152/ajpheart.2001.280.5.H2342. PMID 11299240. S2CID 32049750.
Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y (December 2014). "Prostanoid receptors and acute inflammation in skin". Biochimie. 107 Pt A: 78–81. doi:10.1016/j.biochi.2014.08.010. PMID 25179301.
Cai Y, Ying F, Song E, Wang Y, Xu A, Vanhoutte PM, Tang EH (December 2015). "Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance". FASEB Journal. 29 (12): 4924–36. doi:10.1096/fj.15-274597. PMID 26271253. S2CID 28363263.
Hori R, Nakagawa T, Sugimoto Y, Sakamoto T, Yamamoto N, Hamaguchi K, Ito J (June 2009). "Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma". Neuroscience. 160 (4): 813–9. doi:10.1016/j.neuroscience.2009.03.014. hdl:2433/120543. PMID 19303430. S2CID 23372528.
De Vito V, Salvadori M, Poapolathep A, Owen H, Rychshanova R, Giorgi M (October 2017). "Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit". Journal of Veterinary Pharmacology and Therapeutics. 40 (5): 468–475. doi:10.1111/jvp.12380. PMID 27925221. S2CID 4170611.
Okumura Y, Yamagishi T, Nukui S, Nakao K (March 2017). "Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist". Bioorganic & Medicinal Chemistry Letters. 27 (5): 1186–1192. doi:10.1016/j.bmcl.2017.01.067. PMID 28169162.
Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Moutsianis L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, Gaston JS, Smith M, Bruges-Armas J, Couto AR, Sorrentino R, Paladini F, Ferreira MA, Xu H, Liu Y, Jiang L, Lopez-Larrea C, Díaz-Peña R, López-Vázquez A, Zayats T, Band G, Bellenguez C, Blackburn H, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Corvin A, Craddock N, Deloukas P, Dronov S, Duncanson A, Edkins S, Freeman C, Gillman M, Gray E, Gwilliam R, Hammond N, Hunt SE, Jankowski J, Jayakumar A, Langford C, Liddle J, Markus HS, Mathew CG, McCann OT, McCarthy MI, Palmer CN, Peltonen L, Plomin R, Potter SC, Rautanen A, Ravindrarajah R, Ricketts M, Samani N, Sawcer SJ, Strange A, Trembath RC, Viswanathan AC, Waller M, Weston P, Whittaker P, Widaa S, Wood NW, McVean G, Reveille JD, Wordsworth BP, Brown MA, Donnelly P (July 2011). "Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility". Nature Genetics. 43 (8): 761–7. doi:10.1038/ng.873. PMC 3640413. PMID 21743469.
Haroon N (June 2015). "Ankylosis in ankylosing spondylitis: current concepts". Clinical Rheumatology. 34 (6): 1003–7. doi:10.1007/s10067-015-2956-4. PMID 25935456. S2CID 25930196.
Cornejo-García JA, Perkins JR, Jurado-Escobar R, García-Martín E, Agúndez JA, Viguera E, Pérez-Sánchez N, Blanca-López N (2016). "Pharmacogenomics of Prostaglandin and Leukotriene Receptors". Frontiers in Pharmacology. 7: 316. doi:10.3389/fphar.2016.00316. PMC 5030812. PMID 27708579.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000171522 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000039942 – Ensembl, May 2017

guidetopharmacology.org

"EP4 receptor - Prostanoid receptors - IUPHAR/BPS Guide to PHARMACOLOGY". www.guidetopharmacology.org. Archived from the original on 2 January 2018. Retrieved 6 May 2018.

handle.net

hdl.handle.net

Hori R, Nakagawa T, Sugimoto Y, Sakamoto T, Yamamoto N, Hamaguchi K, Ito J (June 2009). "Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma". Neuroscience. 160 (4): 813–9. doi:10.1016/j.neuroscience.2009.03.014. hdl:2433/120543. PMID 19303430. S2CID 23372528.

harvard.edu

ui.adsabs.harvard.edu

Ichikawa A, Sugimoto Y, Tanaka S (2010). "Molecular biology of histidine decarboxylase and prostaglandin receptors". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (8): 848–66. Bibcode:2010PJAB...86..848I. doi:10.2183/pjab.86.848. PMC 3037517. PMID 20948178.

nih.gov

pubmed.ncbi.nlm.nih.gov

Woodward DF, Jones RL, Narumiya S (September 2011). "International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress". Pharmacological Reviews. 63 (3): 471–538. doi:10.1124/pr.110.003517. PMID 21752876.
Ichikawa A, Sugimoto Y, Tanaka S (2010). "Molecular biology of histidine decarboxylase and prostaglandin receptors". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (8): 848–66. Bibcode:2010PJAB...86..848I. doi:10.2183/pjab.86.848. PMC 3037517. PMID 20948178.
Pang L, Cai Y, Tang EH, Irwin MG, Ma H, Xia Z (2016). "Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy". Journal of Diabetes Research. 2016: 1324347. doi:10.1155/2016/1324347. PMC 4846751. PMID 27190998.
Narumiya S, Sugimoto Y, Ushikubi F (October 1999). "Prostanoid receptors: structures, properties, and functions". Physiological Reviews. 79 (4): 1193–226. doi:10.1152/physrev.1999.79.4.1193. PMID 10508233. S2CID 7766467.
Markovič T, Jakopin Ž, Dolenc MS, Mlinarič-Raščan I (January 2017). "Structural features of subtype-selective EP receptor modulators". Drug Discovery Today. 22 (1): 57–71. doi:10.1016/j.drudis.2016.08.003. PMID 27506873.
Moreno JJ (February 2017). "Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis". European Journal of Pharmacology. 796: 7–19. doi:10.1016/j.ejphar.2016.12.004. PMID 27940058. S2CID 1513449.
Kalinski P (January 2012). "Regulation of immune responses by prostaglandin E2". Journal of Immunology. 188 (1): 21–8. doi:10.4049/jimmunol.1101029. PMC 3249979. PMID 22187483.
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014). "Cyclooxygenase pathways". Acta Biochimica Polonica. 61 (4): 639–49. doi:10.18388/abp.2014_1825. PMID 25343148.
Ushikubi F, Sugimoto Y, Ichikawa A, Narumiya S (August 2000). "Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors". Japanese Journal of Pharmacology. 83 (4): 279–85. doi:10.1254/jjp.83.279. PMID 11001172.
Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR, Skoll A, Vazquez A, Gobeil F, Clyman RI, Chemtob S (May 2001). "Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus". American Journal of Physiology. Heart and Circulatory Physiology. 280 (5): H2342-9. doi:10.1152/ajpheart.2001.280.5.H2342. PMID 11299240. S2CID 32049750.
Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y (December 2014). "Prostanoid receptors and acute inflammation in skin". Biochimie. 107 Pt A: 78–81. doi:10.1016/j.biochi.2014.08.010. PMID 25179301.
Cai Y, Ying F, Song E, Wang Y, Xu A, Vanhoutte PM, Tang EH (December 2015). "Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance". FASEB Journal. 29 (12): 4924–36. doi:10.1096/fj.15-274597. PMID 26271253. S2CID 28363263.
Hori R, Nakagawa T, Sugimoto Y, Sakamoto T, Yamamoto N, Hamaguchi K, Ito J (June 2009). "Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma". Neuroscience. 160 (4): 813–9. doi:10.1016/j.neuroscience.2009.03.014. hdl:2433/120543. PMID 19303430. S2CID 23372528.
De Vito V, Salvadori M, Poapolathep A, Owen H, Rychshanova R, Giorgi M (October 2017). "Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit". Journal of Veterinary Pharmacology and Therapeutics. 40 (5): 468–475. doi:10.1111/jvp.12380. PMID 27925221. S2CID 4170611.
Okumura Y, Yamagishi T, Nukui S, Nakao K (March 2017). "Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist". Bioorganic & Medicinal Chemistry Letters. 27 (5): 1186–1192. doi:10.1016/j.bmcl.2017.01.067. PMID 28169162.
Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Moutsianis L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, Gaston JS, Smith M, Bruges-Armas J, Couto AR, Sorrentino R, Paladini F, Ferreira MA, Xu H, Liu Y, Jiang L, Lopez-Larrea C, Díaz-Peña R, López-Vázquez A, Zayats T, Band G, Bellenguez C, Blackburn H, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Corvin A, Craddock N, Deloukas P, Dronov S, Duncanson A, Edkins S, Freeman C, Gillman M, Gray E, Gwilliam R, Hammond N, Hunt SE, Jankowski J, Jayakumar A, Langford C, Liddle J, Markus HS, Mathew CG, McCann OT, McCarthy MI, Palmer CN, Peltonen L, Plomin R, Potter SC, Rautanen A, Ravindrarajah R, Ricketts M, Samani N, Sawcer SJ, Strange A, Trembath RC, Viswanathan AC, Waller M, Weston P, Whittaker P, Widaa S, Wood NW, McVean G, Reveille JD, Wordsworth BP, Brown MA, Donnelly P (July 2011). "Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility". Nature Genetics. 43 (8): 761–7. doi:10.1038/ng.873. PMC 3640413. PMID 21743469.
Haroon N (June 2015). "Ankylosis in ankylosing spondylitis: current concepts". Clinical Rheumatology. 34 (6): 1003–7. doi:10.1007/s10067-015-2956-4. PMID 25935456. S2CID 25930196.
Cornejo-García JA, Perkins JR, Jurado-Escobar R, García-Martín E, Agúndez JA, Viguera E, Pérez-Sánchez N, Blanca-López N (2016). "Pharmacogenomics of Prostaglandin and Leukotriene Receptors". Frontiers in Pharmacology. 7: 316. doi:10.3389/fphar.2016.00316. PMC 5030812. PMID 27708579.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"PTGER3 prostaglandin e receptor 3 [Homo sapiens (Human)] - Gene - NCBI". Archived from the original on 2016-02-26. Retrieved 2017-01-24.
"PTGER4 prostaglandin e receptor 4 [Homo sapiens (Human)] - Gene - NCBI". Archived from the original on 2017-02-11. Retrieved 2017-02-06.
"Entrez Gene: PTGER4 prostaglandin E receptor 4 (subtype EP4)". Archived from the original on 2010-12-05.
Ichikawa A, Sugimoto Y, Tanaka S (2010). "Molecular biology of histidine decarboxylase and prostaglandin receptors". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 86 (8): 848–66. Bibcode:2010PJAB...86..848I. doi:10.2183/pjab.86.848. PMC 3037517. PMID 20948178.
Pang L, Cai Y, Tang EH, Irwin MG, Ma H, Xia Z (2016). "Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy". Journal of Diabetes Research. 2016: 1324347. doi:10.1155/2016/1324347. PMC 4846751. PMID 27190998.
Kalinski P (January 2012). "Regulation of immune responses by prostaglandin E2". Journal of Immunology. 188 (1): 21–8. doi:10.4049/jimmunol.1101029. PMC 3249979. PMID 22187483.
snpdev. "Reference SNP (refSNP) Cluster Report: rs10440635". www.ncbi.nlm.nih.gov. Archived from the original on 18 February 2017. Retrieved 6 May 2018.
Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Moutsianis L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, Gaston JS, Smith M, Bruges-Armas J, Couto AR, Sorrentino R, Paladini F, Ferreira MA, Xu H, Liu Y, Jiang L, Lopez-Larrea C, Díaz-Peña R, López-Vázquez A, Zayats T, Band G, Bellenguez C, Blackburn H, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Corvin A, Craddock N, Deloukas P, Dronov S, Duncanson A, Edkins S, Freeman C, Gillman M, Gray E, Gwilliam R, Hammond N, Hunt SE, Jankowski J, Jayakumar A, Langford C, Liddle J, Markus HS, Mathew CG, McCann OT, McCarthy MI, Palmer CN, Peltonen L, Plomin R, Potter SC, Rautanen A, Ravindrarajah R, Ricketts M, Samani N, Sawcer SJ, Strange A, Trembath RC, Viswanathan AC, Waller M, Weston P, Whittaker P, Widaa S, Wood NW, McVean G, Reveille JD, Wordsworth BP, Brown MA, Donnelly P (July 2011). "Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility". Nature Genetics. 43 (8): 761–7. doi:10.1038/ng.873. PMC 3640413. PMID 21743469.
Cornejo-García JA, Perkins JR, Jurado-Escobar R, García-Martín E, Agúndez JA, Viguera E, Pérez-Sánchez N, Blanca-López N (2016). "Pharmacogenomics of Prostaglandin and Leukotriene Receptors". Frontiers in Pharmacology. 7: 316. doi:10.3389/fphar.2016.00316. PMC 5030812. PMID 27708579.
"No items found - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 19 February 2017. Retrieved 6 May 2018.
"No items found - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 4 March 2017. Retrieved 6 May 2018.
"PTGER4 prostaglandin e receptor 4 [Homo sapiens (Human)] - Gene - NCBI". Archived from the original on 2018-05-06. Retrieved 2017-02-19.
"No items found - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 4 March 2017. Retrieved 6 May 2018.

semanticscholar.org

api.semanticscholar.org

Narumiya S, Sugimoto Y, Ushikubi F (October 1999). "Prostanoid receptors: structures, properties, and functions". Physiological Reviews. 79 (4): 1193–226. doi:10.1152/physrev.1999.79.4.1193. PMID 10508233. S2CID 7766467.
Moreno JJ (February 2017). "Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis". European Journal of Pharmacology. 796: 7–19. doi:10.1016/j.ejphar.2016.12.004. PMID 27940058. S2CID 1513449.
Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR, Skoll A, Vazquez A, Gobeil F, Clyman RI, Chemtob S (May 2001). "Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus". American Journal of Physiology. Heart and Circulatory Physiology. 280 (5): H2342-9. doi:10.1152/ajpheart.2001.280.5.H2342. PMID 11299240. S2CID 32049750.
Cai Y, Ying F, Song E, Wang Y, Xu A, Vanhoutte PM, Tang EH (December 2015). "Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance". FASEB Journal. 29 (12): 4924–36. doi:10.1096/fj.15-274597. PMID 26271253. S2CID 28363263.
Hori R, Nakagawa T, Sugimoto Y, Sakamoto T, Yamamoto N, Hamaguchi K, Ito J (June 2009). "Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma". Neuroscience. 160 (4): 813–9. doi:10.1016/j.neuroscience.2009.03.014. hdl:2433/120543. PMID 19303430. S2CID 23372528.
De Vito V, Salvadori M, Poapolathep A, Owen H, Rychshanova R, Giorgi M (October 2017). "Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit". Journal of Veterinary Pharmacology and Therapeutics. 40 (5): 468–475. doi:10.1111/jvp.12380. PMID 27925221. S2CID 4170611.
Haroon N (June 2015). "Ankylosis in ankylosing spondylitis: current concepts". Clinical Rheumatology. 34 (6): 1003–7. doi:10.1007/s10067-015-2956-4. PMID 25935456. S2CID 25930196.

web.archive.org

"PTGER3 prostaglandin e receptor 3 [Homo sapiens (Human)] - Gene - NCBI". Archived from the original on 2016-02-26. Retrieved 2017-01-24.
"PTGER4 prostaglandin e receptor 4 [Homo sapiens (Human)] - Gene - NCBI". Archived from the original on 2017-02-11. Retrieved 2017-02-06.
"Entrez Gene: PTGER4 prostaglandin E receptor 4 (subtype EP4)". Archived from the original on 2010-12-05.
"EP4 receptor - Prostanoid receptors - IUPHAR/BPS Guide to PHARMACOLOGY". www.guidetopharmacology.org. Archived from the original on 2 January 2018. Retrieved 6 May 2018.
snpdev. "Reference SNP (refSNP) Cluster Report: rs10440635". www.ncbi.nlm.nih.gov. Archived from the original on 18 February 2017. Retrieved 6 May 2018.
"No items found - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 19 February 2017. Retrieved 6 May 2018.
"No items found - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 4 March 2017. Retrieved 6 May 2018.
"PTGER4 prostaglandin e receptor 4 [Homo sapiens (Human)] - Gene - NCBI". Archived from the original on 2018-05-06. Retrieved 2017-02-19.
"No items found - Gene - NCBI". www.ncbi.nlm.nih.gov. Archived from the original on 4 March 2017. Retrieved 6 May 2018.